• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    西

    西里西亚医科大学

    Medical University of Silesia
    院校EST. 1948
    6,305论文总数
    7.7万引用总数

    The Medical University of Silesia (Polish: Śląski Uniwersytet Medyczny) is a university located in Katowice, Poland.The university has 10,218 students and a teaching staff of 1201, including 295 professors. There are five faculties: Medicine, Dentistry, Pharmacy, Public Health, Health Sciences (includes degrees in nursing, physical therapy, dietetics).

    论文量&引用量时间轴

    机构学者

    论文(6307)

    年份
    起
    –
    止
    排序
    1The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.
    Torsten Zuberbier, Zainab AbdulHameed Ansari,Amir H Abdul Latiff, M, Maria Socorro Agcaoili-De Jesus, Rosana C Agondi,Mona Al-Ahmad,Abdullah A Alangari, H Alhameli, Cesar D Alonso Bello, Saad Alshareef,Salem Al-Tamemi,

    This update and revision of the international guideline for urticaria was developed in accordance with the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is an initiative of the Global Allergy and Asthma Excellence Network (GA2LEN) and its Urticaria and Angioedema Centers of Reference and Excellence (UCAREs and ACAREs), with the participation of 210 delegates from 107 national and international societies, from 59 countries. The consensus conference was held on December 6th, 2024. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell-driven disease, defined by a rapid appearance of wheals, angioedema, or both. The lifetime prevalence of acute urticaria is estimated to be approximately 20%. Chronic urticaria, categorized as either chronic spontaneous urticaria or chronic inducible urticaria, is disabling, impairs quality of life, and affects performance at work and school, however, novel therapies are available. This updated version of the international guideline for urticaria covers the definition and classification of urticaria and outlines expert-guided and evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.

    2026Allergy(2026)引用:14
    引用
    AI阅读
    加入学术空间
    2The Dual Role of GLP-1 Receptor Agonists in Weight Management and Eating Disorders: Potential Benefits and Risks
    Aleksandra Leziak, Klaudia Kochman,Piotr Kocełak

    Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as effective therapies for type 2 diabetes mellitus (T2DM) and obesity, as they improve glycaemic control, promote weight loss and modulate metabolic processes. However, their potent appetite-suppressing effects pose a complex challenge in patients with or at risk of eating disorders (EDs). This narrative review examines the dual role of GLP-1RAs in weight management and in the development or exacerbation of EDs, such as binge eating disorder (BED) and bulimia nervosa (BN). GLP-1RAs have been reported to reduce binge-eating episodes in some trials, but evidence is limited and often inconsistent due to small sample sizes. Conversely, psychiatric adverse effects - including anxiety, depression and disordered eating behaviours - have been observed, raising concerns about the use of these medications in individuals susceptible to EDs. There are case reports of extreme appetite suppression, pathological dietary restriction and psychiatric complications with GLP-1RA therapy, sometimes necessitating discontinuation. Moreover, GLP-1RAs influence brain reward pathways, which may further complicate their impact on eating behaviours. Although these drugs hold promise for mitigating certain ED symptoms, this review highlights the need for caution when prescribing GLP-1RAs to patients with disordered eating and calls for further research to delineate their benefits and risks in this population.

    2026Journal of psychiatric research(2026)引用:5
    引用
    AI阅读
    加入学术空间
    3Transvenous Leadless Pacemaker Extraction: When, Who, Where, and How?
    Mateusz Tajstra, Maciej Dyrbuś,Oskar Kowalski,Maciej Sterliński,Alexander Breitenstein,Daniel Hofer

    The widespread adoption of leadless pacemakers has introduced new clinical and technical challenges related to device management at end-of-service and in the setting of device-related complications. While transvenous lead extraction is an established treatment strategy for conventional pacing systems, there is currently no standardized framework for transvenous leadless pacemaker extraction (TLLE). With increasing numbers of leadless pacemakers approaching end-of-service and expanding indications for leadless pacing, a structured approach to TLLE has become clinically relevant. This review proposes a systematic concept of TLLE, including definitions, clinical indications, procedural strategies, risk assessment, and institutional requirements. Indications for TLLE including device end-of-life, dislocation, interactions, infection, or the need for upgrade to a different device are summarized. Procedural strategies, primarily based on the extraction most frequently from the femoral approach, with the use of snare-based techniques, with the choice of other tools and access tailored to device type, dwell time, fixation mechanism, and degree of encapsulation, are summarized. Literature findings reporting high success rates are presented, with potential complications such as cardiac perforation, tamponade, tricuspid valve injury, embolization, and vascular access complications also summarized. Patient selection and pre-procedural imaging are evaluated, and factors influencing decision-making, including balance of periprocedural risk against long-term implications of device abandonment, are presented.

    2026Kardiologia polska(2026)引用:3
    引用
    AI阅读
    加入学术空间
    4Current Systemic Treatment Options for Advanced Pancreatic Cancer-An Overview Article.
    Małgorzata Domagała-Haduch, Anna Długaszek, Anita Gorzelak-Magiera, Iwona Gisterek-Grocholska

    Pancreatic adenocarcinoma is one of the most aggressive malignancies, with a steadily increasing incidence rate. Due to the asymptomatic nature of early cancer and frequent late diagnosis, only 10-20% of patients are considered for radical treatment. In approximately 40% of patients, local advancement precludes primary surgical treatment, and in approximately half of patients, the cancer is diagnosed at the metastatic stage. Treatment of advanced pancreatic cancer is based on systemic therapy, while a growing number of studies are focusing on the potential use of molecularly targeted agents. The median survival time for metastatic patients treated with FOLFIRINOX chemotherapy is 11 months, compared to 8.5 months for patients treated with gemcitabine and nab-paclitaxel-based chemotherapy. Olaparib in the maintenance treatment of patients with advanced pancreatic cancer prolongs the time to progression compared to placebo but does not affect median overall survival. Immunotherapy and targeted therapy have so far been used in a narrow group of patients with a specific molecular profile, but further research on this cancer offers a real opportunity to develop new treatment approaches. This review article is based on the NCCN (National Comprehensive Cancer Network) guidelines and publications available in the PubMed database.

    2026Biomedicines(2026)引用:3
    引用
    AI阅读
    加入学术空间
    5Cell Line-Dependent Cell Death Pathways Induced by Thymoquinone in Colorectal Cancer Cells.
    Natalia Kurowska, Maria Książek,Paulina Borkowska,Barbara Strzałka-Mrozik

    Colorectal cancer (CRC) remains a leading cause of cancer-related mortality, with resistance to 5-fluorouracil (5-FU) representing a major therapeutic challenge. Thymoquinone (TQ), a bioactive constituent of Nigella sativa, exhibits anticancer activity; however, the mechanisms underlying TQ-induced cell death appear to be highly context dependent. This study aimed to characterize cell line-specific death pathways triggered by TQ in colorectal cancer models with distinct molecular backgrounds and differential responsiveness to 5-FU. Human CRC cell lines RKO (5-FU-sensitive) and SW1116 (poorly responsive), along with normal colon epithelial cells (CCD-841CoN), were treated with TQ, 5-FU, or their combination for 24 h. Cell viability, DNA fragmentation, caspase-3/7, -8, and -9 activity, cell death phenotypes, and expression of apoptosis- and necroptosis-related genes were evaluated using MTT assays, ELISA, luminescent assays, flow cytometry, and RT-qPCR. TQ significantly reduced viability in both CRC cell lines while exerting minimal cytotoxicity toward normal cells. In RKO cells, characterized by microsatellite instability (MSI), TQ induced DNA fragmentation, caspase activation, and transcriptional upregulation of pro-apoptotic genes, consistent with apoptosis-associated signaling. In contrast, SW1116 cells, which exhibit chromosomal instability (CIN) and reduced responsiveness to 5-FU, displayed decreased viability accompanied by suppressed caspase activity and predominant features of caspase-independent necrotic cell death. This differential response may be attributed to the CIN phenotype, which has been associated with impaired apoptotic signaling and enhanced tolerance to cytotoxic stress. Combined TQ and 5-FU treatment did not produce synergistic cytotoxicity, as confirmed by Bliss independence analysis, but revealed distinct, cell line-dependent death programs. These findings demonstrate that TQ modulates cell death execution in a molecular context-dependent manner rather than enhancing 5-FU efficacy through pharmacological synergy.

    2026Molecules (Basel, Switzerland)(2026)引用:2
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 6307 篇论文

    合作机构(100)

    华沙医科大学合作论文 277
    雅盖隆大学合作论文 272
    Medical University of Lodz合作论文 221
    Gdańsk Medical University合作论文 209
    Poznan University of Medical Sciences合作论文 194
    卡托维兹西里西亚大学合作论文 194
    Medical University of Lublin合作论文 162
    西里西亚工业大学合作论文 151
    波兰科学院合作论文 132
    Pomeranian Medical University合作论文 123

    机构统计